Evidence-Based Complementary and Alternative Medicine

Complementary and Integrative Oncology in the Cross-Cultural Region of the Middle East and South Asia


Publishing date
01 Mar 2012
Status
Published
Submission deadline
01 Sep 2011

Lead Editor

1Integrative Oncology Program, The Oncology Service, Lin Medical Center, Clalit Health Services, Haifa, Israel; Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

2Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

3Department of Medicine, Center for Integrative Medicine, Faculty of Health, University of Witten/Herdecke, Witten, Germany

4Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan

5Qasemi Research Center, Baka El-Garbiah, Israel; Arab American University, Jenin, Palestine


Complementary and Integrative Oncology in the Cross-Cultural Region of the Middle East and South Asia

Description

The integration of traditional complementary alternative medicine (CAM) and complementary integrative medicine (CIM) in contemporary cancer care is an emergent field of clinical practice and research throughout the world. The use of herbs, nutrition, mind-body, and spiritual practices is deeply rooted in the cross-cultural mosaic of Middle Eastern and South Asian nations. Recent survey conducted by the Middle-Eastern Research Group in Integrative Oncology (MERGIO), operated in conjunction with the Middle-East Cancer Consortium (MECC), located 145 articles on the theme of CAM and cancer care that had been published in 12 Middle-Eastern countries. Other studies verify the role of the Middle-East as a mediator of medical knowledge from India and other South Asian countries to the Mediterranean.

We wish to invite authors to contribute to this special issue with original research, as well as review articles, that will stimulate scientific work and clinical integration of CIM and traditional medicine into cancer care in the Mediterranean, Middle-East, and South Asia. Potential topics include, but are not limited to:

  • Herbal medicine, diet, mind-body, and spiritual modalities as practiced in major traditional systems of medicine (Ayurveda, Siddha, Jewish, and Greco-Arab)
  • Integration of Western medicine with CIM modalities originated in Middle-Eastern and South Asian systems (Ayurveda and Siddha) of medicine
  • Evidence-based perspective focusing on basic science and clinical research
  • Studies on genomics, epigenomics, and related risk factors
  • Sociological, anthropological, and epidemiological perspectives of CAM use (including understanding of patients' motives for CAM use in cancer care and its ramifications on doctor-patient communication)
  • Historical perspectives of Arab-Islamic, Jewish, Christian, Ayurveda, and Siddha practitioners and their contribution to cancer care
  • Interdisciplinary collaboration of health care professionals and researchers in integrative oncology settings
  • Methodological issues in whole systems and individualization
  • Models of CIM and traditional medicine provision

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 940961
  • - Editorial

Complementary and Integrative Oncology in the Cross-Cultural Region of the Middle East and South Asia

Eran Ben-Arye | Barrie Cassileth | ... | Senthamil R. Selvan
  • Special Issue
  • - Volume 2012
  • - Article ID 670408
  • - Research Article

A Survey of Complementary and Alternative Medicine Use in Cancer Patients Treated with Radiotherapy in Thailand

Putipun Puataweepong | Nongnuj Sutheechet | Panjachat Ratanamongkol
  • Special Issue
  • - Volume 2012
  • - Article ID 936030
  • - Research Article

Zerumbone, a Southeast Asian Ginger Sesquiterpene, Induced Apoptosis of Pancreatic Carcinoma Cells through p53 Signaling Pathway

Songyan Zhang | Qiaojing Liu | ... | Yu Liu
  • Special Issue
  • - Volume 2012
  • - Article ID 693092
  • - Review Article

Reflections on Palliative Care from the Jewish and Islamic Tradition

Michael Schultz | Kassim Baddarni | Gil Bar-Sela
  • Special Issue
  • - Volume 2012
  • - Article ID 401867
  • - Research Article

Barriers to Integration of Traditional and Complementary Medicine in Supportive Cancer Care of Arab Patients in Northern Israel

Eran Ben-Arye | Mariana Steiner | ... | Elad Schiff
  • Special Issue
  • - Volume 2012
  • - Article ID 349040
  • - Review Article

Greco-Arab and Islamic Herbal-Derived Anticancer Modalities: From Tradition to Molecular Mechanisms

Hilal Zaid | Michael Silbermann | ... | Bashar Saad
  • Special Issue
  • - Volume 2012
  • - Article ID 605154
  • - Research Article

Involvement of Prohibitin Upregulation in Abrin-Triggered Apoptosis

Yu-Huei Liu | Konan Peck | Jung-Yaw Lin
  • Special Issue
  • - Volume 2012
  • - Article ID 620619
  • - Research Article

Effectiveness of Core Stability Exercises and Recovery Myofascial Release Massage on Fatigue in Breast Cancer Survivors: A Randomized Controlled Clinical Trial

Irene Cantarero-Villanueva | Carolina Fernández-Lao | ... | Manuel Arroyo-Morales
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate26%
Submission to final decision70 days
Acceptance to publication37 days
CiteScore2.010
Impact Factor1.984
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.